Reacting to the story on Crocin Advance published in Pharmabiz today, a GSKCH spokesperson said, "Keeping in line with GlaxoSmithKline plc’s (GSK plc.) vision to do more, feel better, live longer GlaxoSmithKline Asia Pvt. Ltd.(GSKAP), an Affiliate of GSK plc., launched an advanced variant of Crocin- Crocin Advance in June 2011 under license issued by Drugs Control General (India) on Feb 10, 2011, much before the new regulation was introduced. Crocin Advance is a revolutionary paracetamol tablet that disintegrates five times faster compared to standard paracetamol tablets. The product promises a faster onset of action for the consumer and is allowed to be sold in all states of India."